Home/Supreme Court/Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

181 L. Ed. 2d 394, 132 S. Ct. 570, 565 U.S. 1012, 2011 U.S. LEXIS 7928, 80 U.S.L.W. 3280
Procedural entryThis page is a short order in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S. Read the opinion of the Court — 132 S. Ct. 1670 →
Supreme Court of the United States·Decided November 7, 2011·No. No. 10-844·Published

Opinion

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, 181 L. Ed. 2d 394, 132 S. Ct. 570, 565 U.S. 1012, 2011 U.S. LEXIS 7928, 80 U.S.L.W. 3280 (U.S. 2011).

181 L. Ed. 2d 394 (Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.